Wallis Mechanical Normalization System for Low Back Pain
This study is ongoing, but not recruiting participants.
Sponsor:
Zimmer Spine
Collaborator:
Zimmer, Inc.
Information provided by (Responsible Party):
Zimmer Spine
ClinicalTrials.gov Identifier:
NCT00134537
First received: August 23, 2005
Last updated: October 3, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare improvement in low back pain with Wallis (interspinous process implant) to exercise and injections.
| Condition | Intervention | Phase |
|---|---|---|
|
Low Back Pain |
Device: Interspinous process and dynamic stabilization Device: Conservative Care |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
Resource links provided by NLM:
Further study details as provided by Zimmer Spine:
Primary Outcome Measures:
- To provide a safety cohort for the Prospective, Multi-center, Randomized, Active-Controlled Study of the Wallis System for the Treatment of Mild to Moderate Degenerative Disc Disease of the Lumbar Spine [ Time Frame: 24 months ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 300 |
| Study Start Date: | November 2004 |
| Estimated Study Completion Date: | April 2012 |
| Primary Completion Date: | April 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Interspinous process and dynamic stabilization
|
Device: Interspinous process and dynamic stabilization
Interspinous process and dynamic stabilization
|
|
Active Comparator: 2
Conservative Care
|
Device: Conservative Care
Medication, exercise and spinal injections
|
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Subjects must meet all inclusion and exclusion criteria listed below for participation in the study.
Inclusion Criteria:
- Ages 18-60; male/female.
Diagnosis of mild to moderate degenerative disc disease (DDD), which requires:
- back pain of at least 30/100 as measured on a visual analog scale, with or without leg (radicular) pain; and
- radiographic confirmation of the following, as determined by computed tomography (CT), magnetic resonance imaging (MRI), discography, plain film, myelography and/or flexion/extension films: up to Modic I changes on MRI, with decreased disc height up to 50% of adjacent level, and no significant osteophytes; with or without a contained disc herniation.
- Candidate for either surgery with Wallis or aggressive conservative management.
- Requires treatment at one or two lumbar levels between L1 and L5.
- Experienced symptoms for at least three months without significant resolution.
- Has undergone a regimen of at least four weeks of anti-inflammatory medication for the current episode of back pain and had exposure to physical therapy.
- Minimum baseline Oswestry score of 30% (15/50).
- Physically and mentally able to comply with the protocol, including ability to read and complete required forms, and willing and able to adhere to the follow-up requirements of the protocol.
- Voluntarily signs the subject informed consent.
Exclusion Criteria:
- Significant neuroforaminal compression requiring discectomy or foraminotomy
- Radiographic evidence of DDD at L5-S1
- Radiographic confirmation of severe facet joint disease or degeneration.
- History of any lumbar disc treatment intended to remove the disc, e.g. surgery, intradiscal electrothermal therapy (IDET), laser or enzymes such as chymopapain.
- Clinically compromised vertebral bodies at the affected level due to current or past trauma, e.g., sustained pathological fracture or multiple fractures of vertebrae.
- Unwilling to comply with 8 weeks of physical therapy.
- Subject refuses to consider epidural or facet injections for leg or back pain.
- Active systemic infection or infection at the operative site
- Osteoporosis. The Simple Calculated Osteoporosis Risk Estimation (SCORE) questionnaire will be used to screen subjects for osteoporosis; subjects whose screening suggests risk will undergo a dual-energy x-ray absorptiometry (DEXA) scan. Subjects will be excluded if the DEXA scan results indicate a T-score equal to or worse than -2.5, in accordance with the World Health Organization definition of osteoporosis.
- Paget's disease, osteomalacia, or any other metabolic bone disease other than osteoporosis, which is addressed above
- Rheumatoid arthritis, lupus, or other autoimmune disease
- AIDS, HIV, or Hepatitis
- Known allergy to titanium, polyetheretherketone, or polyester
- Current pathological lesions, such as tumor
- Congenital lumbar spinal stenosis
- Clinically relevant instability on flexion-extension as determined by the investigator by overlaying films.
- Cauda equina syndrome
- Pregnant at time of enrollment or with plans to become pregnant within the next three years
- Concomitant conditions requiring steroid treatment or prior steroid usage for more than one of the preceding three months
- Diabetes mellitus requiring daily insulin management
- Extreme obesity, as defined by National Institutes of Health (NIH) Clinical Guidelines (body mass index [BMI] > 35)
- Fusion previously performed at the same or an adjacent level; or other instrumented spinal surgery at the operative level.
- Prior participation in study of any experimental spinal implant or treatment
- Pending litigation against a health care professional
- Life expectancy of less than three years
- History of any invasive malignancy (except for non-melanoma skin cancer), unless treated with curative intent and with no clinical signs or symptoms of the malignancy for at least 5 years
- Current or recent history of substance abuse (alcoholism and/or narcotic addiction) requiring intervention
- Spondylolysis
- Translation greater than 2 mm at the symptomatic level
- Significant scoliosis (Cobb angle > 25 degrees) or scoliosis otherwise requiring surgical correction
- Kyphosis requiring surgical correction
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00134537
Locations
| United States, Arizona | |
| Spine Specialists of Arizona | |
| Phoenix, Arizona, United States, 85015 | |
| Arizona Institute for Minimally Invasive Spine Care | |
| Phoenix, Arizona, United States, 85020 | |
| United States, California | |
| Spine Source | |
| Beverly Hills, California, United States, 90212 | |
| UCLA Spine Center | |
| Santa Monica, California, United States, 90404 | |
| United States, Colorado | |
| Boulder Neurosurgical Associates | |
| Boulder, Colorado, United States, 80304 | |
| The Spine Education & Research Institute | |
| Thornton, Colorado, United States, 80229 | |
| United States, Georgia | |
| Emory University Medical Center | |
| Atlanta, Georgia, United States, 30329 | |
| United States, Illinois | |
| Illinois Bone & Joint Institute | |
| Morton Grove, Illinois, United States, 60053 | |
| United States, Indiana | |
| Fort Wayne Orthopedics | |
| Fort Wayne, Indiana, United States, 46804 | |
| United States, Maryland | |
| Greater Baltimore Medical Center | |
| Baltimore, Maryland, United States, 21204 | |
| Orthopaedic Associates | |
| Towson, Maryland, United States, 21204 | |
| United States, Missouri | |
| The Orthopedic Center of St. Louis | |
| Chesterfield, Missouri, United States, 63017 | |
| United States, New York | |
| Orthopedic Spine Care of Long Island | |
| Melville, New York, United States, 11747 | |
| United States, Oregon | |
| Orthopedic Spine Associates | |
| Eugene, Oregon, United States, 97401 | |
| United States, Pennsylvania | |
| The Orthopedic Specialty Center (Abington Hospital) | |
| Willow Grove, Pennsylvania, United States, 19090 | |
| United States, Texas | |
| Central Texas Spine Institute | |
| Austin, Texas, United States, 78731 | |
| TBI/ Plano Presbyterian Hospital | |
| Plano, Texas, United States, 75093 | |
Sponsors and Collaborators
Zimmer Spine
Zimmer, Inc.
More Information
No publications provided
| Responsible Party: | Zimmer Spine |
| ClinicalTrials.gov Identifier: | NCT00134537 History of Changes |
| Other Study ID Numbers: | SN002-001-05 |
| Study First Received: | August 23, 2005 |
| Last Updated: | October 3, 2011 |
| Health Authority: | United States: Food and Drug Administration |
Keywords provided by Zimmer Spine:
|
Degenerative Disc Disease of the lumbar spine |
Additional relevant MeSH terms:
|
Back Pain Low Back Pain Pain |
Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013